UIM
ABBV icon

USS Investment Management’s AbbVie ABBV Stock Holding History

USS Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65M Buy
298,983
+9,950
+3% +$2.21M 0.25% 48
2025
Q4 		$66M Sell
289,033
-116
-0% -$26.4K 0.31% 46
2025
Q3 		$66.9M Sell
289,149
-96
-0% -$19.5K 0.3% 48
2025
Q2 		$53.7M Buy
289,245
+1,157
+0.4% +$215K 0.32% 44
2025
Q1 		$60.4M Sell
288,088
-182,642
-39% -$35.5M 0.44% 40
2024
Q4 		$83.7M Sell
470,730
-13,433
-3% -$2.47M 0.58% 36
2024
Q3 		$95.6M Sell
484,163
-1,760
-0.4% -$328K 0.7% 31
2024
Q2 		$83.3M Buy
485,923
+8,092
+2% +$1.34M 0.66% 29
2024
Q1 		$86.9M Buy
477,831
+4,242
+0.9% +$731K 0.71% 28
2023
Q4 		$73.4M Sell
473,589
-30,806
-6% -$4.49M 0.65% 28
2023
Q3 		$75.2M Buy
504,395
+12,989
+3% +$1.91M 0.81% 24
2023
Q2 		$66.2M Buy
491,406
+8,281
+2% +$1.21M 0.78% 23
2023
Q1 		$77M Buy
483,125
+10,059
+2% +$1.54M 1.05% 10
2022
Q4 		$76.5M Sell
473,066
-1,212
-0.3% -$186K 1.07% 10
2022
Q3 		$63.7M Sell
474,278
-129,969
-22% -$18.7M 0.93% 13
2022
Q2 		$92.7M Sell
604,247
-26,322
-4% -$4.02M 0.93% 13
2022
Q1 		$102M Buy
630,569
+14,675
+2% +$2.13M 0.84% 15
2021
Q4 		$83.4M Hold
615,894
– – 0.63% 20
2021
Q3 		$66.4M Buy
615,894
+62,546
+11% +$7.15M 0.56% 34
2021
Q2 		$62.3M Hold
553,348
– – 0.49% 54
2021
Q1 		$59.9M Hold
553,348
– – 0.52% 55
2020
Q4 		$59.2M Sell
553,348
-43,762
-7% -$4.21M 0.54% 53
2020
Q3 		$52.3M Buy
597,110
+2,186
+0.4% +$206K 0.5% 51
2020
Q2 		$58.4M Buy
594,924
+294,804
+98% +$26M 0.61% 49
2020
Q1 		$22.8M Buy
300,120
+263,220
+713% +$22.4M 0.31% 79
2019
Q4 		$3.27M Buy
+36,900
New +$3.06M 0.03% 134

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

USS Investment Management's ABBV Position: Q1 2026 in Review

USS Investment Management increased its AbbVie (ABBV) stake by 3.4% in Q1 2026, buying an estimated $2.21M and bringing the position to 298,983 shares worth $65M. The position accounts for 0.25% of the portfolio, ranked #48.

USS Investment Management first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $102M in Q1 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • USS Investment Management held 298,983 shares of AbbVie worth $65M as of Q1 2026.
  • USS Investment Management bought 9,950 AbbVie shares in Q1 2026, an estimated $2.21M.
  • AbbVie made up 0.25% of USS Investment Management's portfolio in Q1 2026, its #48 holding.
  • USS Investment Management first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • USS Investment Management's AbbVie position peaked at $102M in Q1 2022.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on USS Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.